Troutman Pepper advised Viridian Therapeutics on the deal. Viridian Therapeutics, In announced that it had issued shares in an underwritten public offering resulting in Viridian receiving approximately...
Viridian Therapeutics’ Follow-On Public Offering
Botanix Pharmaceuticals Limited’s Acquisition of Sofpironium Bromide
Troutman Pepper advised Botanix Pharmaceuticals Limited on the deal. Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel,...